MECHANISM OF ACTION
AOD-9604 is a small piece snipped from the end of human growth hormone. Researchers at Monash University discovered that this specific fragment carries the fat-burning signal but not the growth signal. It works by switching on the fat-breakdown process (called lipolysis) inside fat cells. Crucially, it does not raise IGF-1 (a growth factor that builds muscle) or mess with blood sugar levels, two side effects associated with full growth hormone. It progressed through several rounds of formal clinical study before the research programme was wound down.
RESEARCH APPLICATIONS
- Adipose tissue metabolism research
- Beta-3 adrenergic pathway studies
- GH-fragment comparative pharmacology
- Metabolic signalling research models
RESEARCH HIGHLIGHTS
Fragment behaves unlike whole GH
2001Laboratory work reports the fragment acting on lipolytic pathways without the IGF-1 signalling associated with full growth hormone - the main reason it is studied separately. Research observations only.
Ref: Heffernan et al., Endocrinology
RESEARCH PROTOCOL NOTES
Chemical Identity
Sequence
Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
Storage & Stability
Lyophilised: 2–8°C or -20°C. Reconstituted: 2–8°C, 28 days. More stable than many larger GH-related peptides.
Regulatory Status
Unscheduled in South Africa. Supplied for laboratory and research use only. Not a registered medicine, not evaluated by SAHPRA, not for human consumption. Not explicitly listed on the WADA prohibited list.
Important - read before proceeding
This page is a summary of published scientific literature about a molecule. It is provided for research and educational purposes only. Nothing on this page is medical advice, a diagnosis, a recommendation, a prescription, or a claim that this compound treats, cures, prevents or improves any condition in humans. Research findings described here are observations reported by third-party researchers about the molecule - they are not statements about the product supplied by Bio Intelligence, and they should not be read as an expected outcome.
Compounds supplied are not registered medicines, have not been evaluated by SAHPRA, and are not for human consumption. No dosing, route of administration or usage guidance is provided by Bio Intelligence. If you have a health concern, speak to a registered healthcare practitioner.